Clinical Trials Directory

Trials / Completed

CompletedNCT00891540

Local Infiltration Analgesia With Ropivacaine Versus Placebo in Caesarean Section

Lokal Infiltrations Analgesi Med Ropivakain 0,5 % Versus Ropivakain 0,2 % Versus Placebo Efter Sectio Caesarea: et Prospektivt, Dobbeltblindet, Placebokontrolleret Studie.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Hvidovre University Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare systematic local infiltration with Ropivacaine 0.5 % versus Ropivacaine 0.2 % versus Placebo in patients undergoing elective caesarean section. The hypothesis is that systemic local infiltration will reduce pain and postoperative opioid consumption.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaineRopivacaine 0.5%
DRUGRopivacaineRopivacaine 0.2%
DRUGplaceboIsotonic NaCl

Timeline

Start date
2009-07-01
Primary completion
2010-05-01
Completion
2010-05-01
First posted
2009-05-01
Last updated
2011-06-23

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00891540. Inclusion in this directory is not an endorsement.